Document Type
Article
Publication Date
Spring 4-2014
Abstract
Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated with IVIG with a review of the medical literature to identify the optimal timing and clinical characteristics for this treatment strategy.
Recommended Citation
Shah N, Shaaban H, Spira R, Slim J, Boghossian J. Intravenous immunoglobulin in the treatment of severe Clostridium difficile colitis. J Global Infect Dis 2014;6:82¬85
Comments
The copy of record is available at http://dx.doi.org/10.4103%2F0974-777X.132053. Copyright © 2014 Journal of Global Infectious Diseases. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.